Awarded

Trastuzumab deruxtecano 100 mg Pó conc sol inj Fr IV

Name: Trastuzumab deruxtecano 100 mg Pó conc sol inj Fr IV
Creator: Unidade Local de Saúde de Coimbra, EPE
Published: 2026-10-29
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Portuguese

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Unidade Local de Saúde de Coimbra, EPE
Winners: Daiichi Sankyo Portugal Unipessoal, Lda.
Contract value: €1,209,900
Bids received: 1
Published: 29 Oct 2026
Awarded: 9 Oct 2026
Contract start: 9 Oct 2026
Contract end: 22 Oct 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Região de Coimbra
Source: Original notice on TED (757372-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
RISDIPLAM 5 MG COMP	Unidade Local de Saúde de Coimbra, EPE	ROCHE Farmacêutica Química, LDA	€741,405	27 Oct 2026
Tafasitamab 200 mg Pó conc sol inj Fr IV	Unidade Local de Saúde de Coimbra, EPE	Cencora 3Pl Portugal, S.A.	€126,324	26 Oct 2026
Pemigatinib 13.5 mg Comp	Unidade Local de Saúde de Coimbra, EPE	Cencora 3Pl Portugal, S.A.	€136,627	26 Oct 2026
Tocilizumab 20 mg/ml Sol inj Fr 4 ml IV	Unidade Local de Saúde de Coimbra, EPE	ROCHE Farmacêutica Química, LDA	—	26 Oct 2026
Tocilizumab 162 mg/0.9 ml Sol inj Caneta 0.9 ml SC	Unidade Local de Saúde de Coimbra, EPE	ROCHE Farmacêutica Química, LDA	€473,664	26 Oct 2026
ZANUBRUTINIB 160 MG COMP	Unidade Local de Saúde de Coimbra, EPE	Cencora 3Pl Portugal, S.A.	€454,109	23 Oct 2026